bf/NASDAQ:CKPT_icon.jpeg

NASDAQ:CKPT

Checkpoint Therapeutics, Inc.

  • Stock

USD

Last Close

2.66

26/07 20:00

Market Cap

82.24M

Beta: 1.44

Volume Today

471.19K

Avg: 295.57K

PE Ratio

−0.73

PFCF: −0.75

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-13.89M
-
-22.46M
61.68%
-22.68M
0.96%
-36.37M
60.37%
-24.71M
32.04%
-23.08M
6.61%
-56.67M
145.53%
-62.62M
10.51%
-51.85M
17.21%
depreciation and amortization
324K
-
deferred income tax
-324K
-
stock based compensation
3.25M
-
3.87M
18.91%
3.12M
19.39%
1.99M
36.03%
3.12M
56.52%
2.78M
10.93%
3.14M
12.84%
2.92M
6.79%
2.90M
0.92%
change in working capital
1.55M
-
1.23M
21.04%
1.40M
14.34%
6.00M
328.01%
-3.03M
150.42%
-1.77M
41.61%
19.60M
1,208.37%
-4.61M
123.52%
-5.08M
10.13%
accounts receivables
1.51M
-
6K
99.60%
3K
50%
-56K
1,966.67%
inventory
-1.51M
-
-6K
99.60%
-3K
50%
56K
1,966.67%
accounts payables
1.88M
-
2.70M
43.34%
6.72M
149.02%
-5.04M
175.03%
-833K
83.48%
18.77M
2,352.70%
-4.62M
124.63%
-5.08M
9.80%
other working capital
1.55M
-
-656K
142.21%
-1.30M
97.56%
-716K
44.75%
2.02M
381.42%
-935K
146.40%
831K
188.88%
14K
98.32%
5.08M
36,150%
other non cash items
7.98M
-
7.42M
7.03%
2.70M
63.65%
2.56M
4.93%
3.25M
26.73%
5.52M
69.89%
7.63M
38.29%
6.75M
11.49%
1.36M
79.86%
net cash provided by operating activities
-1.11M
-
-9.95M
798.01%
-15.46M
55.39%
-25.80M
66.90%
-21.37M
17.17%
-16.55M
22.56%
-26.31M
58.94%
-57.55M
118.79%
-47.59M
17.31%
investments in property plant and equipment
-2.52M
-
-3.16M
25.15%
-400K
87.34%
acquisitions net
purchases of investments
sales maturities of investments
other investing activites
net cash used for investing activites
-2.52M
-
-3.16M
25.15%
-400K
87.34%
debt repayment
-2.79M
-
common stock issued
51.50M
-
570K
98.89%
30.99M
-
27.57M
11.04%
33.27M
20.66%
41.28M
24.08%
17.62M
57.31%
common stock repurchased
-6K
-
dividends paid
other financing activites
2.55M
-
-2.42M
-
-2.12M
12.49%
-2.02M
4.49%
-1.01M
50.02%
-2.73M
170%
40.45M
1,583.31%
net cash used provided by financing activities
54.05M
-
-2.22M
104.11%
28.57M
-
25.45M
10.92%
31.25M
22.75%
40.27M
28.88%
14.89M
63.03%
40.45M
171.71%
effect of forex changes on cash
3.63M
-
net change in cash
54.05M
-
-15.33M
128.37%
-15.86M
3.45%
2.77M
117.46%
4.08M
47.36%
14.70M
260.00%
13.96M
4.98%
-42.67M
405.57%
-7.14M
83.27%
cash at beginning of period
-3.63M
-
50.42M
1,487.78%
35.09M
30.41%
19.23M
45.21%
22.00M
14.41%
26.08M
18.56%
40.77M
56.35%
54.73M
34.25%
12.07M
77.95%
cash at end of period
50.42M
-
35.09M
30.41%
19.23M
45.21%
22.00M
14.41%
26.08M
18.56%
40.77M
56.35%
54.73M
34.25%
12.07M
77.95%
4.93M
59.16%
operating cash flow
-1.11M
-
-9.95M
798.01%
-15.46M
55.39%
-25.80M
66.90%
-21.37M
17.17%
-16.55M
22.56%
-26.31M
58.94%
-57.55M
118.79%
-47.59M
17.31%
capital expenditure
-2.52M
-
-3.16M
25.15%
-400K
87.34%
free cash flow
-3.63M
-
-13.11M
260.86%
-15.86M
20.98%
-25.80M
62.69%
-21.37M
17.17%
-16.55M
22.56%
-26.31M
58.94%
-57.55M
118.79%
-47.59M
17.31%

All numbers in USD (except ratios and percentages)